ARDX Ardelyx

Watchlist

4.5100 +0.1400+3.20% Close 11/30 16:00 ET

4.5300+0.0200+0.44% Post 18:58 ET

4.5650High4.3700Low5.37MVolume

About Ardelyx Company

Ardelyx, Inc. is a biopharmaceutical company. It engages in the research, development, and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Waltham, MA.

Company Profile

SymbolARDX

Company NameArdelyx

Listing Date06/19/2014

Issue Price14.00

Founded2007

CEOMr. Michael G. Raab

MarketNASDAQ

Employees133

Securities TypeOrdinary Shares

Fiscal Year Ends12-31

Address400 Fifth Avenue,Suite 210

CityWaltham

ProvinceMassachusetts

CountryUnited States of America

Zip Code02451

Phone1-510-745-1700

Websitehttp://www.ardelyx.com

Company Executives

Name
Position
Salary

Michael G. Raab
Director, President and Chief Executive Officer
1.95M

Justin A. Renz
Chief Financial and Operations Officer
1.73M

David P. Rosenbaum
Chief Development Officer
2.01M

Elizabeth Grammer
Chief Legal and Administrative Officer
1.73M

Susan Rodriguez
Chief Commercial Officer
1.04M

Robert Blanks
Chief Regulatory Affairs and Quality Assurance Officer
1.70M

Dr. Laura Williams, M.D.
Chief Medical Officer
1.06M

Robert Felsch
Chief Accounting Officer
--

David M. Mott
Chairman of the Board
141.65K

Richard J. Rodgers
Independent Director
114.15K

William C. Bertrand, Jr
Independent Director
106.65K

Dr. Jan M. Lundberg, PhD
Independent Director
91.65K

Robert B. Bazemore, Jr
Independent Director
94.15K

Onaiza Cadoret-Manier
Independent Director
91.65K

Muna Bhanji
Independent Director
94.15K